Page last updated: 2024-11-06

dracorhodin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dracorhodin: no other info available 8/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69509
CHEMBL ID486600
MeSH IDM0167679

Synonyms (19)

Synonym
5-methoxy-6-methyl-2-phenyl-7h-chromen-7-one
643-56-1
7h-1-benzopyran-7-one, 5-methoxy-6-methyl-2-phenyl-
dracorhodin
nsc234485
nsc-234485
c.i. 75210
5-methoxy-6-methyl-2-phenyl-7h-1-benzopyran-7-one
5-methoxy-6-methyl-2-phenylchromen-7-one
CHEMBL486600
c4tsx5m53x ,
nsc 234485
unii-c4tsx5m53x
UCZJPQIEFFTIEV-UHFFFAOYSA-N
5-methoxy-6-methyl-2-phenyl-7h-chromen-7-one #
DTXSID20214526
AKOS030559703
CS-0032075
HY-N4081

Research Excerpts

Overview

Dracorhodin is a major constituent of "Dragon's blood" resin of Daemonorops draco Willd.

ExcerptReferenceRelevance
"Dracorhodin is a major constituent found in "Dragon's blood" resin of Daemonorops draco Willd. "( Single-step purification of dracorhodin from dragon's blood resin of Daemonorops draco using high-speed counter-current chromatography combined with pH modulation.
Hu, R; Lu, Y; Shi, J; Sun, C; Wu, T, 2009
)
2.09

Effects

ExcerptReferenceRelevance
"Dracorhodin perchlorate has been recently shown to induce apoptotic cell death in cancer cells. "( Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53, and enhances apoptosis.
Ali, M; Ding, C; Khan, M; Li, X; Ma, T; Rasul, A; Yi, F, 2012
)
3.26

Compound-Compound Interactions

ExcerptReferenceRelevance
" The isolated fraction of counter-current chromatography was determined by HPLC, NMR, UV/visible and ESI/MS combined with pH modulation, since dracorhodin is unstable in solution which exists in different forms depending on pH values."( Single-step purification of dracorhodin from dragon's blood resin of Daemonorops draco using high-speed counter-current chromatography combined with pH modulation.
Hu, R; Lu, Y; Shi, J; Sun, C; Wu, T, 2009
)
0.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID400164Antimicrobial activity against Staphylococcus aureus ATCC 13709 by agar dilution-streak method
AID1808022Inhibition of porcine heart malate dehydrogenase assessed as critical aggregation concentration preincubated for 5 min followed by nicotinamide adenine dinucleotide addition and monitered for 90 sec by spectrophotometric method2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
AID400168Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 by agar dilution-streak method
AID400172Antimicrobial activity against Candida albicans ATCC 10231 by agar dilution-streak method
AID400167Antimicrobial activity against Salmonella gallinarum ATCC 9184 at 100 mcg/mL by agar dilution-streak method
AID400166Antimicrobial activity against Escherichia coli ATCC 9637 at 100 mcg/mL by agar dilution-streak method
AID400170Antimicrobial activity against Mycobacterium smegmatis ATCC 607 by agar dilution-streak method
AID1808021Inhibition of porcine heart malate dehydrogenase assessed as reduction in enzyme inhibition at 3 times IC50 preincubated for 5 min followed by nicotinamide adenine dinucleotide addition and monitered for 90 sec in presence of 0.01% Triton-X100 by spectrop2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
AID1808020Inhibition of porcine heart malate dehydrogenase preincubated for 5 min followed by nicotinamide adenine dinucleotide addition and monitered for 90 sec by spectrophotometric method2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.70)18.7374
1990's2 (7.41)18.2507
2000's7 (25.93)29.6817
2010's14 (51.85)24.3611
2020's3 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.41 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index24.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]